24×7 Emergency Care

1-8-31/1, Minister Road, Secunderabad, Telangana 500003

EMERGENCY:Sudden severe drop attack (Tumarkin's crisis) causing injury, or a Menière's attack with new headache or neurological symptoms —call040-46324365immediately — 24 hours, 7 days— 24/7

VESTIBULAR AND BALANCE DISORDERS

Menière's Disease — Specialist Diagnosis and Management in Hyderabad at KIMS

Menière's disease is a chronic, episodic disorder of the inner ear characterised by recurrent attacks that combine vertigo, fluctuating hearing loss, tinnitus, and a sensation of pressure or fullness in the affected ear — all arising together in the same episode. It was first described by the French physician Prosper Menière in 1861, who correctly identified the inner ear as the source of what had previously been attributed to the brain. The underlying pathological process is endolymphatic hydrops — an accumulation of excess endolymph (the fluid that fills the inner ear's membranous labyrinth) that distends the cochlear and vestibular membranes until they periodically rupture, producing the characteristic attack.

View Our Specialists

Menière's disease is a chronic, episodic disorder of the inner ear caused by endolymphatic hydrops — excess accumulation of endolymph (inner ear fluid) distending the membranous labyrinth. The excess endolymph periodically ruptures the membranes (particularly Reissner's membrane), mixing the potassium-rich endolymph with the perilymph. This potassium influx depolarises the hair cells and nerve endings, producing the acute attack. The AAO-HNS 2020 diagnostic criteria define the classic tetrad that must occur together in the same episode: (1) Episodic vertigo lasting 20 minutes to 12 hours (typically 20 min–2 hours); (2) Low-frequency sensorineural hearing loss on audiogram (fluctuating initially, progressive over years); (3) Tinnitus — typically roaring or low-pitched — in the affected ear; (4) Aural fullness. Between attacks, the patient is typically normal early in the disease. Over years: progressive permanent hearing loss; bilateral disease in 20–50%. Audiological test: ECochG, SP/AP ratio >0.4 suggests endolymphatic hydrops. Treatment: low-salt diet (<1,500 mg/day) and diuretics first; betahistine; intratympanic therapy (gentamicin for vestibular ablation, dexamethasone for hearing-dominant disease) when conservative management fails.

The tetrad — all four in the same episode: The clinical diagnostic precision of Menière's lies in the co-occurrence of all four features in the same episode. Vertigo alone is BPPV or vestibular neuritis. Tinnitus and hearing loss alone is sensorineural hearing loss from other causes. The simultaneous occurrence of ALL four — spinning, ear fullness, roaring tinnitus, and dulled hearing — arising and resolving together over 20 minutes to 2 hours is the pathognomonic pattern. Duration distinguishes from BPPV (<1 minute) and vestibular neuritis (days). Ear symptoms often warn of an impending attack — patients recognise the 'aura'.
Endolymphatic hydrops mechanism — rupture and recovery: Excess endolymph builds up under increasing pressure in the scala media of the cochlea and the vestibular labyrinth. When pressure exceeds the membrane's strength, Reissner's membrane ruptures, releasing potassium-rich endolymph into the scala vestibuli (perilymph). The sudden potassium influx depolarises vestibular hair cells (vertigo + nystagmus) and cochlear hair cells (hearing loss + tinnitus). Once the rupture seals (20 minutes to 2 hours), ionic imbalance resolves and hair cells recover — vertigo subsides and hearing partially recovers. Over years, cumulative hair cell damage produces permanent hearing loss.
Tumarkin's crisis — the sudden drop attack: Tumarkin's otolithic crisis: sudden unexplained falls without any warning, without loss of consciousness, without vertigo at the moment of falling. Caused by acute dysfunction of the otolithic organs (utricle and saccule) — producing a sudden false signal of body tilt that the motor system instantly responds to by falling. The patient may be mid-sentence, mid-step, or standing still. Falls can be violent and cause serious injury. Tumarkin's crises are a major safety concern and an indication for interventional treatment (intratympanic gentamicin to ablate residual vestibular function and prevent further attacks). Occurs in ~6% of Menière's patients.
Intratympanic gentamicin — vestibular ablation: Intratympanic gentamicin is injected through the tympanic membrane into the middle ear, diffuses across the round window membrane into the inner ear. Gentamicin is selectively toxic to vestibular hair cells (at low doses) while relatively sparing cochlear hair cells. The result: chemical ablation of ipsilateral vestibular function, eliminating the source of the abnormal vestibular signals. The trade-off: permanently reduced vestibular function on that side (the contralateral labyrinth compensates over weeks of VRT). Success rate: >90% control of vertigo attacks. Conducted at KIMS by ENT/otoneurology in patients with disabling attacks not responding to conservative management.
ECochG — the electrodiagnostic signature of hydrops: Electrocochleography (ECochG) records electrical potentials generated in the cochlea in response to sound clicks. The summating potential (SP) reflects the DC offset of the cochlear receptor potential — abnormally elevated in endolymphatic hydrops from increased endolymph pressure. The action potential (AP) is the compound action potential of the cochlear nerve. SP/AP ratio >0.4 is diagnostic of endolymphatic hydrops and supports the Menière's diagnosis. ECochG is available at KIMS as part of the diagnostic assessment for suspected Menière's, particularly when the audiometric picture does not unambiguously show the characteristic low-frequency pattern.
Diet and India — the low-salt challenge: Low dietary sodium (<1,500 mg/day) is the cornerstone of conservative Menière's management. Salt restriction reduces sodium available for renal reabsorption, which reduces endolymph secretion. The challenge for Indian patients: salt is present in large quantities in traditional Indian foods not perceived as 'salty' — pickles (achaar) can contain 1,000–2,000 mg sodium per tablespoon; papadums; instant noodles; restaurant meals; chai masala. At KIMS, dietary counselling for Menière's is specifically adapted for Indian dietary patterns, with a list of common high-sodium Indian foods and practical low-sodium alternatives.
Bilateral Menière's — 20–50% over time: Bilateral involvement develops in 20–50% of Menière's patients over the course of their illness, typically becoming apparent 5–15 years after first presentation. Bilateral profound deafness — while rare — represents one of the most disabling outcomes. Cochlear implantation is an option for profound bilateral deafness in Menière's, as the cochlear nerve remains intact (deafness is from hair cell loss, not nerve loss). Bilateral disease significantly increases the complexity of vestibular management: intratympanic gentamicin cannot be used bilaterally (would ablate both labyrinths and prevent all vestibular compensation).

Fact	Details
AAO-HNS 2020 diagnostic criteria	All 4 in the same episode: (1) Episodic vertigo 20 min–12h · (2) Low-frequency SNHL on audiogram · (3) Ipsilateral tinnitus (roaring) · (4) Aural fullness · At least 2 documented episodes before definite diagnosis
Audiological signature	Low-frequency SNHL (250–1000 Hz) · Fluctuates initially (worse during/after attack, partially recovers) · Progressive over years to flat SNHL · ECochG: SP/AP ratio >0.4 = hydrops
Tumarkin's crisis	Sudden drop attacks without warning, no LOC · 6% of Menière's patients · Serious injury risk · Indication for intratympanic gentamicin
Conservative treatment	Low-salt diet <1,500 mg/day (first and most important) · Diuretics (HCTZ + triamterene) · Betahistine 24–48 mg TDS · Caffeine restriction · Stress management
Interventional treatment	Intratympanic dexamethasone (hearing-dominant disease, hearing preservation) · Intratympanic gentamicin (vestibular ablation, attack control >90%) · Endolymphatic sac surgery · Labyrinthectomy (if deaf)
Bilateral disease	20–50% over time · Greater disability · Cochlear implant for profound bilateral deafness
India-specific	Low-salt diet counselling adapted for Indian cuisine: pickles, papadums, restaurant meals, instant noodles all high in hidden sodium · Practical substitution list at KIMS

About This Condition

Menière's Disease at a Glance

Prevalence

17–513 per 100,000 (wide range due to diagnostic variability) · Typically presents in 4th–5th decade · Female:male approximately 1.3:1.

Pathophysiology

Endolymphatic hydrops: excess endolymph distends the membranous labyrinth · Periodic rupture of Reissner's membrane or other membranes mixes endolymph with perilymph · Potassium-rich endolymph depolarises hair cells and nerves (producing the attack) · Rupture seals; hair cells recover (explains the fluctuating nature early in the disease).

Classic tetrad (AAO-HNS 2020 criteria)

(1) Episodic vertigo: 20 min–2 hours (not seconds as in BPPV, not days as in neuritis) · (2) Low-frequency sensorineural hearing loss on audiogram · (3) Ipsilateral tinnitus (roaring or low-pitched) · (4) Aural fullness (pressure or blocked sensation in the ear) · All four occurring together in episodes.

Audiological signature

Low-frequency SNHL (250–1000 Hz) · Fluctuates initially: worse during/after attacks, partially recovers · Progresses to flat SNHL over years · Electrocochleography (ECochG): SP/AP ratio >0.4 suggests hydrops.

Drop attacks (Tumarkin's crisis)

Sudden falls without warning from acute otolithic organ dysfunction · No loss of consciousness · Serious injury risk · Indication for more aggressive treatment.

Bilateral disease

Occurs in 20–50% over time · Greater disability · Bilateral profound deafness rare but possible · Cochlear implant for profound bilateral deafness.

Conservative treatment

Dietary salt restriction (<1,500 mg/day) · Diuretics (hydrochlorothiazide + triamterene) · Betahistine 24–48 mg TDS · Stress reduction · Caffeine restriction.

Interventional treatment

Intratympanic gentamicin (chemical ablation of vestibular function) · Intratympanic steroids (dexamethasone) for hearing-dominant disease · Endolymphatic sac surgery · Vestibular nerve section (rare) · Labyrinthectomy (if deaf).

About This Condition

Menière's Disease — Episodic Inner-Ear Hydrops With Vertigo, Tinnitus, Hearing Loss, and Aural Fullness

Menière's disease is both disabling and distressing: the unpredictability of attacks (which can occur without warning and completely incapacitate the person for 20 minutes to several hours) profoundly disrupts work, driving, social activities, and quality of life. Over years, the hearing loss becomes progressive and permanent rather than fluctuating, and the tinnitus may become constant. Management at KIMS targets attack suppression (dietary modification, diuretics, betahistine) and, for refractory disease, selective ablation of the vestibular function of the affected ear while preserving hearing (intratympanic gentamicin).

Otoneurology Consultation

Speak directly with the KIMS otoneurology, audiology, and neurology teams — for episodic vertigo with hearing loss and tinnitus, audiogram and VNG/VEMP testing, intratympanic dexamethasone or gentamicin, and end-stage management including hearing aids and cochlear implant evaluation.

040-44885000Combined ENT + Neurology Menière's clinic

Endolymphatic Hydrops, Fluctuation, and Tumarkin's Crisis

Pathophysiology and Attack Cycle

Endolymphatic hydrops — the fluid pressure that builds before an attack

The membranous labyrinth — the fluid-filled tube within the bony cochlea and semicircular canals — is divided into two fluid compartments: the endolymph space (inside the membranous tube, filled with high-potassium endolymph) and the perilymph space (outside the membranous tube, filling the bony labyrinth). These two fluids have very different ionic compositions and must be kept completely separate — their mixing is toxic to the hair cells. In Menière's disease, the endolymph accumulates excessively, possibly from impaired reabsorption via the endolymphatic sac or from overproduction. As the endolymph pressure builds, the membranous walls distend. When the pressure exceeds the structural integrity of Reissner's membrane (which separates the scala media from the scala vestibuli), the membrane ruptures, mixing the high-potassium endolymph with the perilymph. The potassium-rich fluid bathing the hair cells and auditory/vestibular nerves produces rapid, chaotic depolarisation — experienced as the attack of vertigo, hearing loss, and tinnitus. Over the following minutes to hours, the membrane seals, the ionic composition normalises, and the attack resolves.

Why symptoms fluctuate in early Menière's but become permanent over time

Early in Menière's disease, the hair cells recover after each attack because the potassium exposure is temporary and the cells are not permanently destroyed. This is why hearing returns to near-normal between attacks in the early years. Over years of recurrent attacks, however, cumulative hair cell loss occurs: each attack destroys a proportion of cochlear hair cells (which cannot regenerate), and the hearing loss gradually becomes permanent and progressive, evolving from a low-frequency pattern toward a flat or high-frequency predominant SNHL. Similarly, the vestibular hair cells accumulate damage, and in late disease the vestibular hypofunction becomes permanent — paradoxically reducing the frequency of acute vertigo attacks (because the vestibular system on the affected side is now chronically impaired and cannot generate sudden imbalance signals) while leaving the patient with chronic unsteadiness.

Drop attacks — the sudden falls of Tumarkin's crisis

Tumarkin's otolithic crisis is a sudden, violent fall without any warning and without loss of consciousness, caused by an acute otolithic pressure wave that produces a sudden inappropriate signal from the saccule or utricle. The patient describes being thrown or pushed to the ground by an invisible force — with no dizziness, no vertigo, and no loss of consciousness before the fall. The danger: the fall occurs without any protective mechanism (no stumble, no time to reach for support) and causes significant injury in approximately 20–40% of cases. Tumarkin's crisis is an indication for more aggressive treatment, typically intratympanic gentamicin, because it poses a serious injury risk.

Diagnosis at KIMS

Menière's disease is diagnosed at KIMS through a structured four-stage workflow that begins with pure tone audiometry to document the characteristic low-frequency fluctuating sensorineural hearing loss, supports the clinical diagnosis with electrocochleography for endolymphatic hydrops, characterises vestibular function with VNG, caloric testing, and VEMP, and reserves delayed gadolinium-enhanced MRI for direct endolymph visualisation in atypical or bilateral cases :

Audiometry — the essential diagnostic test

Pure tone audiogram (PTA): characteristic low-frequency (250–1000 Hz) sensorineural hearing loss · Comparison of thresholds during vs between attacks (fluctuation) · Speech discrimination testing · Tympanometry: normal (B-type tympanogram in middle ear pathology — exclude otitis media as cause of hearing loss). Serial audiometry over months documents the progressive nature of hearing loss.

Electrocochleography (ECochG)

ECochG measures the electrical response of the cochlea to sound and calculates the summating potential to action potential ratio (SP/AP ratio). In endolymphatic hydrops, the SP is enhanced (the cochlear membranes are stretched) · SP/AP ratio >0.4 (or >0.35 in some criteria) is supportive of hydrops · Not diagnostic alone but supports clinical diagnosis.

Videonystagmography (VNG) + caloric testing

Between attacks: usually normal or mild unilateral vestibular hypofunction on caloric testing · During an attack: intense spontaneous nystagmus (ipsilateral to affected ear during the excitatory phase, contralateral during the inhibitory phase) · VEMP (vestibular evoked myogenic potentials): reduced or absent cVEMP amplitude on the affected side (saccular dysfunction).

Gadolinium-enhanced MRI — endolymph imaging

Delayed gadolinium-enhanced MRI of the inner ear (3–4 hours after IV or intratympanic gadolinium injection): gadolinium enters the perilymph but not the endolymph · The enlarged endolymph appears as a non-enhancing (dark) space surrounded by enhancing perilymph · Direct visualisation of endolymphatic hydrops · Available at KIMS for atypical or bilateral cases.

Treatment

Management at KIMS

Conservative First-Line · Interventional for Refractory Disease

Stepwise Menière's Disease Care Pathway

Dietary salt restriction — Conservative (First-Line): Less than 1,500 mg sodium per day · The most consistently beneficial lifestyle intervention · Reduces endolymph pressure · Attack frequency often halves within 4–6 weeks.

Diuretics — Conservative (First-Line): Hydrochlorothiazide 25–50 mg + triamterene 37.5–75 mg once daily (Dyazide) · Or acetazolamide 250 mg BD · Monitor electrolytes.

Betahistine — Conservative (First-Line): 16–24 mg three times daily (high-dose betahistine 48 mg TDS in some protocols) · Histamine H3 antagonist · Increases blood flow to the stria vascularis and endolymphatic sac · Reduces attack frequency in most patients over 4–6 months.

Vestibular suppressants for acute attacks — Conservative (First-Line): Prochlorperazine 12.5 mg IM or 5 mg oral · Or dimenhydrinate 50 mg · Short-term only (for the acute attack) · Not for daily use.

Intratympanic dexamethasone — Interventional (Refractory Disease): Steroid injected through the eardrum into the middle ear · Diffuses into inner ear · Anti-inflammatory effect · Reduces attack frequency without affecting hearing · Repeated injections often needed · Preferred when hearing preservation is a priority.

Intratympanic gentamicin — Interventional (Refractory Disease): Ototoxic aminoglycoside injected into middle ear · Selectively destroys vestibular hair cells (vestibulotoxic at low doses) · Ablates the pathological vestibular function of the affected ear · Reduces or eliminates vertigo attacks in 85–90% · Risk of hearing loss (5–20% depending on technique) · Used when vertigo control outweighs hearing preservation concerns (or in deaf Menière's).

Endolymphatic sac surgery — Interventional (Refractory Disease): Decompression or shunting of the endolymphatic sac · Aims to reduce hydrops · Evidence less robust than gentamicin · Some centres use as hearing-preserving first-line intervention before gentamicin.

Related Conditions

Menière's disease belongs to the family of vestibular and balance disorders evaluated and managed at KIMS Neuroscience. Explore related conditions

BPPV Central Vertigo

FAQs

Frequently Asked Questions

What your doctor is telling you is about the natural history of Menière's disease over years. In the early phase of the disease — which is where you are now — the hearing loss and tinnitus fluctuate: they worsen during attacks and recover between them. This is because the hair cells in the cochlea are stressed during the attack (from the potassium flooding their environment) but are not permanently destroyed, so they recover. Over years, however, repeated attacks gradually accumulate permanent hair cell damage. The low-frequency hearing loss becomes fixed rather than fluctuating, then expands to include more frequencies, and eventually the hearing on the affected side may be significantly and permanently reduced. This is why treating Menière's disease early — starting with a strict low-salt diet (under 1,500 mg sodium per day) + diuretics + betahistine — is important: reducing the frequency and severity of attacks reduces cumulative hair cell damage and preserves hearing for longer. Call 040-44885000.

With inadequate control on conservative treatment, the interventional options are: (1) Intratympanic steroid injection (dexamethasone): dexamethasone is injected through the eardrum under local anaesthesia as an outpatient procedure. It reduces attack frequency in 60–70% of patients with good hearing preservation. Multiple injections are often needed, and the effect may last 4–6 months. This is the preferred next step when hearing preservation is important. (2) Intratympanic gentamicin: a low dose of the antibiotic gentamicin (which is vestibulotoxic at low doses) is injected into the middle ear. It selectively destroys the vestibular hair cells of the affected ear, stopping the attack-generating process. Attack control is achieved in 85–90% of patients, but there is a 5–20% risk of worsening hearing loss. It is preferred when the hearing is already poor on the affected side or when vertigo control is the priority. At KIMS, the otoneurology team discusses these options individually based on hearing status and attack severity. Call 040-44885000.

What you are describing is Tumarkin's otolithic crisis — a sudden drop attack from Menière's disease. During these attacks, a sudden pressure wave in the endolymph sends a violent, brief, incorrect signal from the saccule or utricle to the spinal cord, which suddenly changes your postural muscle tone — causing you to fall instantly without any premonitory dizziness or warning. There is no loss of consciousness. This is one of the most dangerous features of Menière's disease because the fall is completely unpredicted and there is no opportunity to protect yourself. Tumarkin's attacks are a strong indication for more aggressive treatment: intratympanic gentamicin is particularly effective for controlling these attacks (approximately 85–90% reduction) and should be discussed urgently with the otoneurology team at KIMS given the injury risk. You should not drive during this period. Call 040-44885000 urgently.

The pattern you describe — reduced attack frequency after many years but progressive hearing loss and constant tinnitus — is the natural history of late-stage Menière's disease. The reduced attack frequency occurs because the vestibular hair cells of the affected ear have been progressively destroyed over years and can no longer generate the sudden hydrops-driven attacks. For the tinnitus: (1) Tinnitus retraining therapy (TRT) and cognitive-behavioural therapy (CBT) for tinnitus are the most evidence-based approaches for managing chronic, distressing tinnitus · (2) Sound therapy (low-level background noise or white noise) reduces tinnitus perception by reducing the contrast between the tinnitus and the environment · (3) Hearing aids: correcting the hearing loss with amplification simultaneously reduces tinnitus perception and improves quality of life. For the hearing loss: if the affected ear has profound hearing loss and the opposite ear has good hearing, a CROS hearing aid system can help. If both ears have significant hearing loss, cochlear implant in the affected ear should be evaluated. At KIMS, audiology and otoneurology provide the full late-stage Menière's management. Call 040-44885000.

An ear that fills with pressure before the world starts spinning. A roaring sound that announces the next attack is coming. A hearing loss that is slowly but surely getting worse. Menière's disease is manageable — and in most patients, the attacks can be controlled.

At KIMS Hyderabad, otoneurology, audiology, and neurology work together for every Menière's patient. Call 040-44885000.

040-44885000

International enquiries: info@kimsneurosciences.com